These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 14962262

  • 21. Changes in WT1 splicing are associated with a specific gene expression profile in Wilms' tumour.
    Baudry D, Faussillon M, Cabanis MO, Rigolet M, Zucker JM, Patte C, Sarnacki S, Boccon-Gibod L, Junien C, Jeanpierre C.
    Oncogene; 2002 Aug 15; 21(36):5566-73. PubMed ID: 12165855
    [Abstract] [Full Text] [Related]

  • 22. Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.
    Cilloni D, Renneville A, Hermitte F, Hills RK, Daly S, Jovanovic JV, Gottardi E, Fava M, Schnittger S, Weiss T, Izzo B, Nomdedeu J, van der Heijden A, van der Reijden BA, Jansen JH, van der Velden VH, Ommen H, Preudhomme C, Saglio G, Grimwade D.
    J Clin Oncol; 2009 Nov 01; 27(31):5195-201. PubMed ID: 19752335
    [Abstract] [Full Text] [Related]

  • 23. Detectable Wilms' tumor-1 transcription at treatment completion is associated with poor prognosis of acute myeloid leukemia: a single institution's experience.
    Yamauchi T, Negoro E, Lee S, Takai M, Matsuda Y, Takagi K, Kishi S, Tai K, Hosono N, Tasaki T, Ikegaya S, Yoshida A, Urasaki Y, Iwasaki H, Ueda T.
    Anticancer Res; 2013 Aug 01; 33(8):3335-40. PubMed ID: 23898100
    [Abstract] [Full Text] [Related]

  • 24. Reduction in WT1 gene expression during early treatment predicts the outcome in patients with acute myeloid leukemia.
    Andersson C, Li X, Lorenz F, Golovleva I, Wahlin A, Li A.
    Diagn Mol Pathol; 2012 Dec 01; 21(4):225-33. PubMed ID: 23111196
    [Abstract] [Full Text] [Related]

  • 25. [Expression of Wilms' tumor gene (WT1) in leukemias and its clinical implication].
    Wu X, Wang Y, Pei X.
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jan 01; 19(1):16-9. PubMed ID: 10921096
    [Abstract] [Full Text] [Related]

  • 26. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
    Roberts DJ, Haber D, Sklar J, Crum CP.
    Lab Invest; 1993 May 01; 68(5):528-36. PubMed ID: 8388523
    [Abstract] [Full Text] [Related]

  • 27. High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients.
    Miyoshi Y, Ando A, Egawa C, Taguchi T, Tamaki Y, Tamaki H, Sugiyama H, Noguchi S.
    Clin Cancer Res; 2002 May 01; 8(5):1167-71. PubMed ID: 12006533
    [Abstract] [Full Text] [Related]

  • 28. Correlation of minimal residual disease by assessing Wilms tumor gene expression and engraftment by variable number of tandem repeats in children with leukemia posthematopoietic stem cell transplantation.
    Olszewski M, Chou PM, Huang W, Tallman S, Kletzel M.
    Pediatr Dev Pathol; 2006 May 01; 9(3):203-9. PubMed ID: 16944968
    [Abstract] [Full Text] [Related]

  • 29. [Clinical significance of multidrug resistance gene(mdr1) expression in patients with acute leukemia].
    Dong Z, Luo J, Xu W.
    Zhonghua Zhong Liu Za Zhi; 1997 Jan 01; 19(1):72-5. PubMed ID: 10743063
    [Abstract] [Full Text] [Related]

  • 30. Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease.
    Qin Y, Zhu H, Jiang B, Li J, Lu X, Li L, Ruan G, Liu Y, Chen S, Huang X.
    Leuk Res; 2009 Mar 01; 33(3):384-90. PubMed ID: 18950857
    [Abstract] [Full Text] [Related]

  • 31. Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia.
    Iwasaki T, Sugisaki C, Nagata K, Takagi K, Takagi A, Kojima T, Ito M, Nakamura S, Naoe T, Murate T.
    Pathol Int; 2007 Oct 01; 57(10):645-51. PubMed ID: 17803653
    [Abstract] [Full Text] [Related]

  • 32. The significance of detecting WT1 expression in childhood acute leukemias.
    Hu SY, Gu WY, Chen ZX, Wang XL, Cen JN, He HL, Chai YH, Chen CS.
    Pediatr Hematol Oncol; 2010 Nov 01; 27(8):581-91. PubMed ID: 20863155
    [Abstract] [Full Text] [Related]

  • 33. Anaplasia and drug selection-independent overexpression of the multidrug resistance gene, MDR1, in Wilms' tumor.
    Re GG, Willingham MC, el Bahtimi R, Brownlee NA, Hazen-Martin DJ, Garvin AJ.
    Mod Pathol; 1997 Feb 01; 10(2):129-36. PubMed ID: 9127318
    [Abstract] [Full Text] [Related]

  • 34. MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients.
    Illmer T, Schuler US, Thiede C, Schwarz UI, Kim RB, Gotthard S, Freund D, Schäkel U, Ehninger G, Schaich M.
    Cancer Res; 2002 Sep 01; 62(17):4955-62. PubMed ID: 12208746
    [Abstract] [Full Text] [Related]

  • 35. Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association.
    Renneville A, Boissel N, Zurawski V, Llopis L, Biggio V, Nibourel O, Philippe N, Thomas X, Dombret H, Preudhomme C.
    Cancer; 2009 Aug 15; 115(16):3719-27. PubMed ID: 19536888
    [Abstract] [Full Text] [Related]

  • 36. Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors.
    Udtha M, Lee SJ, Alam R, Coombes K, Huff V.
    Oncogene; 2003 Jun 12; 22(24):3821-6. PubMed ID: 12802290
    [Abstract] [Full Text] [Related]

  • 37. Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation.
    Cilloni D, Messa F, Gottardi E, Fava M, Arruga F, Defilippi I, Carturan S, Messa E, Morotti A, Giugliano E, Rege-Cambrin G, Alberti D, Baccarani M, Saglio G.
    Cancer; 2004 Sep 01; 101(5):979-88. PubMed ID: 15329907
    [Abstract] [Full Text] [Related]

  • 38. Combinatorial molecular marker assays of WT1, survivin, and TERT at initial diagnosis of adult acute myeloid leukemia.
    Kim HJ, Choi EJ, Sohn HJ, Park SH, Min WS, Kim TG.
    Eur J Haematol; 2013 Nov 01; 91(5):411-22. PubMed ID: 23826993
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of minimal residual disease by real-time quantitative PCR of Wilms' tumor 1 expression in patients with acute myelogenous leukemia after allogeneic stem cell transplantation: correlation with flow cytometry and chimerism.
    Kwon M, Martínez-Laperche C, Infante M, Carretero F, Balsalobre P, Serrano D, Gayoso J, Pérez-Corral A, Anguita J, Díez-Martín JL, Buño I.
    Biol Blood Marrow Transplant; 2012 Aug 01; 18(8):1235-42. PubMed ID: 22281301
    [Abstract] [Full Text] [Related]

  • 40. Minimal residual disease detection in acute myeloid leukemia by mutant nucleophosmin (NPM1): comparison with WT1 gene expression.
    Barragan E, Pajuelo JC, Ballester S, Fuster O, Cervera J, Moscardo F, Senent L, Such E, Sanz MA, Bolufer P.
    Clin Chim Acta; 2008 Sep 01; 395(1-2):120-3. PubMed ID: 18590714
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.